Research Summary
Analyzed using Evidence Intelligence™

Telemedicine Improves Glycemic Control in Older Diabetics

Last updated August 29, 2026

Key finding

After 3 months, patients in the intervention group showed significant (P <.05) improvement in postprandial plasma glucose level.

This study evaluated the effectiveness of a mobile health system in improving glycemic control among older Chinese patients with type 2 diabetes mellitus (T2DM). Results indicated significant improvements in postprandial plasma glucose and glycated hemoglobin levels.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Extended (5–20+ y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the effectiveness of a mobile health system in improving glycemic control among older Chinese patients with type 2 diabetes mellitus (T2DM). Results indicated significant improvements in postprandial plasma glucose and glycated hemoglobin levels.

Clinical relevance

Improving glycemic control is crucial for older adults with T2DM to reduce the risk of complications. This study highlights the potential of mobile health technologies to support diabetes management, suggesting that such interventions could be integrated into routine care for older patients to enhance their health outcomes.

Keep in mind

Unclear effectiveness due to limited evidence pairs. Potential selection bias in participant recruitment. Results may not be generalizable to younger populations.

Published in

Journal Reference

Publication details and source links for this paper.

Gunther E, Katharina S, Peter R, et al. Mobile Phone–Based Telemedicine Apps Help Improve Glycemic Control in Older Chinese Patients with T2DM. JMIR mHealth and uHealth. 2019;7(1):e10664. doi:10.2196/10664

Main Effects

Postprandial plasma glucose decreased by 2.48 mmol/L in the intervention group (P = 0.004).

Glycated hemoglobin (HbA1c) levels decreased by 1.07% in the intervention group (P = 0.045).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to mHealth diabetes support intervention and Glucose iAUC (OGTT), HbA1c.

Primary intervention

mHealth diabetes support intervention

Primary outcomes

  • Glucose iAUC (OGTT)
  • HbA1c

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

2
Evidence pairs
2
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 56

2

Related topics

2

Evidence pairs

817

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 2 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

mHealth Diabetes Support Interventions and HbA1c

Related evidence

Evidence relationship

mHealth Diabetes Support Interventions and Postprandial and OGTT Glucose

Save evidence

Evidence topic

Glycemic Control

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Glucose iAUC (OGTT)

mHealth diabetes support intervention → Glucose iAUC (OGTT)

mHealth diabetes support intervention → Glucose iAUC (OGTT)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HbA1c

mHealth diabetes support intervention → HbA1c

mHealth diabetes support intervention → HbA1c

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 4 studies
ImpactScore™
69
Positive
ConsistencyScore™
67
generally_consistent
Supporting studies: Based on 4 studies
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Postprandial plasma glucose improved significantly by 2.48 mmol/L.
  • Glycated hemoglobin (HbA1c) decreased by 1.07% in the intervention group.
who this applies

Who this applies to

  • Older adults aged 60 and above.
  • Patients diagnosed with type 2 diabetes mellitus (T2DM).
keep in mind

Keep in Mind

  • Results may vary based on individual patient characteristics.
  • Further studies are needed to confirm long-term effectiveness.
  • The intervention's impact on quality of life was not assessed.
between the lines

Between the Lines

  • Unclear effectiveness due to limited evidence pairs.
  • Potential selection bias in participant recruitment.
  • Results may not be generalizable to younger populations.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on mHealth Diabetes Support Interventions and HbA1c, mHealth Diabetes Support Interventions and Postprandial and OGTT Glucose.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does mHealth Diabetes Support Interventions improve HbA1c?

Strong Evidence

mHealth Diabetes Support Interventions may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on 6 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
6 supporting studiesUpdated: Aug 2026

Does mHealth Diabetes Support Interventions improve postprandial and ogtt glucose?

Moderate Evidence

mHealth Diabetes Support Interventions appears to improve Postprandial and OGTT Glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Glucose iAUC (OGTT)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

  • Only a small number of supporting studies are available.
  • Population details are unavailable.
2 supporting studiesUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.